Outcome of Stroke With Mild or Rapidly Improving Symptoms-Reference-Cited by-同舟云学术

Outcome of Stroke With Mild or Rapidly Improving Symptoms

Published:2007-09 Issue:9 Volume:38 Page:2531-2535
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Nedeltchev Krassen¹,Schwegler Benjamin¹,Haefeli Tobias¹,Brekenfeld Caspar¹,Gralla Jan¹,Fischer Urs¹,Arnold Marcel¹,Remonda Luca¹,Schroth Gerhard¹,Mattle Heinrich P.¹

Affiliation:

1. From the Departments of Neurology (K.N., B.S., T.H., U.F., M.A., H.P.M.) and Neuroradiology (C.B., J.G., L.R., G.S.), University Hospital of Bern, Bern, Switzerland.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference20 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Intra-arterial Prourokinase for Acute Ischemic Stroke

3. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)

4. Why are stroke patients excluded from TPA therapy?: An analysis of patient eligibility

5. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should patients with minor strokes be given thrombolytics?;Stroke and Vascular Neurology;2024-08-03

2. General and Specific Quality of Life Course of Individuals with Different Levels of Stroke Severity: A One-Year Prospective Longitudinal Study;Clinical Gerontologist;2024-06-13

3. Intravenous thrombolysis versus dual antiplatelet therapy for patients with acute minor ischaemic stroke: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-06-10

4. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial;The Lancet;2024-06

5. A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial;International Journal of Stroke;2024-05-17